Tanya Skamene

Dr. Tanya Skamene completed her MD (in 2010), internal medicine and hematology training (in 2015) at McGill University, followed by a 12-month clinical trials fellowship focusing on the design and conduct of phase II/III clinical trials at the Canadian Cancer Trials Group. During her fellowship, she completed a secondary analysis of the LY.12 randomized clinical trial evaluating outcomes of patients with peripheral T-cell lymphoma, which has been accepted for publication in Leukemia & Lymphoma. In addition, she received the John H. Crookston award by the Canadian Hematology Society and an American Society of Hematology Abstract achievement award in 2016 for her project on wait times for autologous stem cell transplantation in relapsed or refractory lymphoma. Her clinical area of interest is in hematologic malignancies and geriatric oncology.